Cargando…

Initial Preserved Renal Function as a Predictor of Favorable Renal Response to Rituximab in Refractory or Relapsing Lupus Nephritis: A Single-center Cohort Study in Korea

OBJECTIVE: Previous studies investigating the beneficial effect of rituximab on lupus nephritis (LN) reported controversial results There have been few reports of renal response to rituximab according to renal function We investigated the efficacy of rituximab in refractory/relapsing LN and the role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Su Jin, Ahn, Soo Min, Oh, Ji Seon, Hong, Seokchan, Lee, Chang-Keun, Yoo, Bin, Kim, Yong-Gil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Rheumatology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324915/ https://www.ncbi.nlm.nih.gov/pubmed/37476702 http://dx.doi.org/10.4078/jrd.2022.29.1.22

Ejemplares similares

Long-term renal outcomes of patients with non-proliferative lupus nephritis
por: Kang, Eun-Song, et al.
Publicado: (2023)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis
por: Hong, Seokchan, et al.
Publicado: (2020)

Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE
por: Gilbert, Mileka, et al.
Publicado: (2021)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

Clinical and histological significance of urinary CD11c(+) macrophages in lupus nephritis
por: Kim, Jihye, et al.
Publicado: (2020)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

Relapse and Outcome of Lupus Nephritis After Renal Transplantation in the Modern Immunosuppressive Era
por: Pattanaik, Debendra, et al.
Publicado: (2022)

Renal microvascular lesions in lupus nephritis
por: Ding, Ying, et al.
Publicado: (2019)

Renal Mononuclear Phagocytes in Lupus Nephritis
por: Davidson, Anne
Publicado: (2021)

Progression to End-Stage Renal Disease Due to IgG4-Related Nephritis Refractory to Rituximab
por: Nguyen, Tien, et al.
Publicado: (2023)

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016)

Comparison of renal remission and relapse‐free rate in initial‐ and delayed‐onset lupus nephritis
por: Suzuki, Eiji, et al.
Publicado: (2021)

Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019)

Discovery of urine biomarkers for lupus nephritis via quantitative and comparative proteome analysis
por: Kwon, Oh Chan, et al.
Publicado: (2021)

Secukinumab on Refractory Lupus Nephritis
por: Costa, Rita, et al.
Publicado: (2021)

The spectrum of renal thrombotic microangiopathy in lupus nephritis
por: Song, Di, et al.
Publicado: (2013)

Prediction of prognosis and renal outcome in lupus nephritis
por: Parodis, Ioannis, et al.
Publicado: (2020)

Lupus Nephritis Associated With Renal Cell Carcinoma
por: Mehta, Vivek, et al.
Publicado: (2022)

Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study
por: Vigna-Perez, Mónica, et al.
Publicado: (2006)

Immunoglobulin Binding Protein 1 as a Potential Urine Biomarker in Patients with Lupus Nephritis
por: Lee, Eun-Ju, et al.
Publicado: (2019)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
por: Petricca, Luca, et al.
Publicado: (2020)

Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023)

Daratumumab monotherapy for refractory lupus nephritis
por: Roccatello, Dario, et al.
Publicado: (2023)

Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis
por: Gonzalo-Gil, Elena, et al.
Publicado: (2018)

Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus?
por: Maziad, Asmaa S. Abu, et al.
Publicado: (2017)

Unmasking Renal Disease in Systemic Lupus Erythematosus: Beyond Lupus Nephritis
por: Nunez Cuello, Lisandra, et al.
Publicado: (2023)

O07 Managing relapsing and refractory lupus nephritis in juvenile systemic lupus erythematosus: a case report
por: Javed, Farhan, et al.
Publicado: (2021)

Role of early repeated renal biopsies in lupus nephritis
por: Zickert, A, et al.
Publicado: (2014)

Reversible dysregulation of renal circadian rhythm in lupus nephritis
por: Mishra, Rakesh, et al.
Publicado: (2021)

Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab
por: Aftab, Adan, et al.
Publicado: (2022)

Urine SERPINC1/ORM1 as biomarkers for early detection of lupus nephritis in MRL-lpr mice
por: Kim, Young-Eun, et al.
Publicado: (2023)

Tozinameran: Relapse of lupus nephritis: case report
Publicado: (2021)

Homozygous FCGR3A-158F mutation is associated with delayed B-cell depletion following rituximab but with preserved efficacy in a patient with refractory lupus nephritis
por: Seret, Guillaume, et al.
Publicado: (2013)

Renal deposits of complement factors as predictors of end-stage renal disease and death in patients with lupus nephritis
por: Koopman, Jacob J E, et al.
Publicado: (2020)

Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
por: Trachana, M, et al.
Publicado: (2011)

Management of refractory lupus nephritis: challenges and solutions
por: Yo, JH, et al.
Publicado: (2019)

The renal metallothionein expression profile is altered in human lupus nephritis
por: Faurschou, Mikkel, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_eqojh0to1euju4av726sen74sa